全球生物安全櫃市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計生物安全櫃市場將從 2025 年的 2.7321 億美元成長到 2034 年的 4.6513 億美元，2026 年至 2034 年的複合年成長率為 6.09%。

由於對無污染實驗室環境的需求日益成長，全球生物安全櫃市場正經歷顯著成長。這些安全櫃對於保護實驗室人員、檢體和環境免受有害生物因素的侵害至關重要。製藥、生技和醫療保健領域研究活動的拓展是推動市場成長的主要因素。

關鍵促進因素包括醫療基礎設施投資增加、實驗室檢測量上升以及生物安全法規日益嚴格。新冠疫情凸顯了實驗室安全設備的重要性，促使生物安全櫃的使用量大幅提升。過濾系統和生物安全櫃設計的進步也提高了其性能和效率。

預計未來市場將保持強勁成長，主要得益於生命科學研究和疫苗研發的持續進展。對感染疾病控制和實驗室安全標準的日益重視也可能進一步擴大市場需求。隨著全球研究活動的不斷擴展，生物安全櫃預計仍將是實驗室基礎設施的關鍵組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生物安全櫃市場：依產品類型分類

• 市場分析、洞察與預測
• 一級
• 二類
• 三級

第5章 全球生物安全櫃市場：依應用分類

• 市場分析、洞察與預測
• 危險藥物的處理
• 非危險藥物的處理
• 其他產品處理

第6章 全球生物安全櫃市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 診斷和檢測實驗室
• 學術研究機構
• 其他（CRO、CMO、專科診所等）

第7章 全球生物安全櫃市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Labconco Corporation
  • Esco Micro Pte. Ltd
  • The Baker Company
  • NuAire Inc
  • Germfree Laboratories LLC
  • Euroclone SpA
  • Kewaunee International Group
  • Telstar（azbil Group）
  • Biobase Biodusty（Shandong）
  • Co. Ltd
  • Air Science USA LLC

The Biological Safety Cabinet Market size is expected to reach USD 465.13 Million in 2034 from USD 273.21 Million (2025) growing at a CAGR of 6.09% during 2026-2034.

The global biological safety cabinet market is growing significantly due to increasing demand for contamination-free laboratory environments. These cabinets are essential for protecting laboratory personnel, samples, and the environment from harmful biological agents. The expansion of research activities in pharmaceuticals, biotechnology, and healthcare is a major factor driving market growth.

Key drivers include rising investments in healthcare infrastructure, increasing laboratory testing, and stringent biosafety regulations. The COVID-19 pandemic highlighted the importance of safety equipment in laboratories, leading to increased adoption of biological safety cabinets. Advancements in filtration systems and cabinet designs are also improving performance and efficiency.

Looking ahead, the market is expected to witness strong growth with continued advancements in life sciences research and vaccine development. Increasing focus on infectious disease control and laboratory safety standards will further drive demand. As research activities continue to expand globally, biological safety cabinets will remain a critical component of laboratory infrastructure.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Class I
• Class II
• Class III

By Application

• Hazardous Drug Handling
• Non-hazardous Drug Handling
• Other Product Handling

By End-User

• Pharmaceutical & Biotechnology Companies
• Diagnostic & Testing Laboratories
• Academic & Research Institutes
• Others (CROs, CMOs, Specialty Clinics, etc.)

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Labconco Corporation, Esco Micro Pte Ltd, The Baker Company, NuAire Inc, Germfree Laboratories LLC, Euroclone SpA, Kewaunee International Group, Telstar azbil Group, Biobase Biodusty Shandong, Co Ltd, Air Science USA LLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Class I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Class II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Class III Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Hazardous Drug Handling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-hazardous Drug Handling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Product Handling Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic & Testing Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others (CROs, CMOs, Specialty Clinics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOLOGICAL SAFETY CABINET INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Labconco Corporation
  • 9.2.3 Esco Micro Pte. Ltd
  • 9.2.4 The Baker Company
  • 9.2.5 NuAire Inc
  • 9.2.6 Germfree Laboratories LLC
  • 9.2.7 Euroclone SpA
  • 9.2.8 Kewaunee International Group
  • 9.2.9 Telstar (azbil Group)
  • 9.2.10 Biobase Biodusty (Shandong)
  • 9.2.11 Co. Ltd
  • 9.2.12 Air Science USA LLC